Rush University Medical Center , Chicago, Illinois , USA.
CHRU de Besançon, Université de Franche-Comté , Besançon , France.
RMD Open. 2016 Jul 7;2(2):e000235. doi: 10.1136/rmdopen-2015-000235. eCollection 2016.
To evaluate the responsiveness of a simple routine assessment of patient index data (RAPID3)-like index that includes only 3 patient self-report measures (physical function, pain and patient global estimate) compared to that of traditional composite indices to assess change in patients with axial spondyloarthritis (Ax-SpA).
Devenir des Spondylarthropathies Indifférenciées Récentes (DESIR) is a prospective cohort of patients with inflammatory back pain suggestive of Ax-SpA. The study included 461 patients, who met the Assessment of SpondyloArthritis International Society (ASAS) classification criteria for Ax-SpA. A simple RAPID3-like index was compared with the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the AS Disease Activity Score (ASDAS) scores for responsiveness over 6 months. Construct validity was also evaluated through Pearson correlations and discrimination of disease activity through standardised mean differences for the 3 indices.
The RAPID3-like index was correlated significantly with BASDAI (r=0.84, p<0.005) and ASDAS-C-reactive protein (CRP) (r=0.74, p<0.005), similar to correlations of BASDAI with ASDAS-CRP (r=0.76, p<0.005). The percentage of patients with inactive disease ranged from 9% to 25% and with high activity from 10% to 45%, according to various measures. The capacity to discriminate between high and low disease activity was similar for the 3 indices. The strength of agreement of RAPID3 with ASDAS-CRP was moderate (0.44) and lower with BASDAI (0.37). Responsiveness over 6 months was slightly higher for ASDAS-CRP and the RAPID3-like index than that for BASDAI.
The RAPID3-like index provides similar information to BASDAI and ASDAS-CRP concerning responsiveness over 6 months. RAPID3 appears feasible to assess patients with Ax-SpA quantitatively over time in busy clinical settings.
评估一种简单的常规患者指数数据评估(RAPID3)样指数的反应性,该指数仅包括 3 项患者自我报告的测量指标(身体功能、疼痛和患者总体估计),与传统综合指数相比,该指数在评估轴性脊柱关节炎(Ax-SpA)患者的变化方面更具反应性。
Devenir des Spondylarthropathies Indifférenciées Récentes(DESIR)是一项前瞻性炎症性背痛患者队列研究,这些患者提示存在 Ax-SpA。该研究纳入了 461 名符合评估脊柱关节炎国际协会(ASAS)Ax-SpA 分类标准的患者。在 6 个月内,将简单的 RAPID3 样指数与 Bath 强直性脊柱炎疾病活动指数(BASDAI)和 AS 疾病活动评分(ASDAS)进行比较,以评估其反应性。通过 Pearson 相关性和 3 项指数的标准化均数差来评估结构效度和疾病活动的区分度。
RAPID3 样指数与 BASDAI(r=0.84,p<0.005)和 ASDAS-C 反应蛋白(CRP)(r=0.74,p<0.005)显著相关,与 BASDAI 与 ASDAS-CRP 的相关性相似(r=0.76,p<0.005)。根据不同的测量指标,无疾病活动的患者比例范围为 9%至 25%,高疾病活动的患者比例范围为 10%至 45%。3 项指数在区分高、低疾病活动方面的能力相似。RAPID3 与 ASDAS-CRP 的一致性强度为中度(0.44),与 BASDAI 的一致性强度较低(0.37)。6 个月时,ASDAS-CRP 和 RAPID3 样指数的反应性略高于 BASDAI。
RAPID3 样指数在 6 个月的反应性方面提供了与 BASDAI 和 ASDAS-CRP 相似的信息。RAPID3 似乎可以在繁忙的临床环境中对 Ax-SpA 患者进行定量评估。